<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Sanchez Fernandez I</submitter><funding>NICHD NIH HHS</funding><funding>NINDS NIH HHS</funding><pagination>386-394</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC5272971</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>88(4)</volume><pubmed_abstract>&lt;h4>Objective&lt;/h4>To compare refractory convulsive status epilepticus (rSE) management and outcome in children with and without a prior diagnosis of epilepsy and with and without a history of status epilepticus (SE).&lt;h4>Methods&lt;/h4>This was a prospective observational descriptive study performed from June 2011 to May 2016 on pediatric patients (1 month-21 years of age) with rSE.&lt;h4>Results&lt;/h4>We enrolled 189 participants (53% male) with a median (25th-75th percentile) age of 4.2 (1.3-9.6) years. Eighty-nine (47%) patients had a prior diagnosis of epilepsy. Thirty-four (18%) patients had a history of SE. The time to the first benzodiazepine was similar in participants with and without a diagnosis of epilepsy (15 [5-60] vs 16.5 [5-42.75] minutes, p = 0.858). Patients with a diagnosis of epi</pubmed_abstract><journal>Neurology</journal><pubmed_title>Refractory status epilepticus in children with and without prior epilepsy or status epilepticus.</pubmed_title><pmcid>PMC5272971</pmcid><funding_grant_id>K23 NS075363</funding_grant_id><funding_grant_id>R01 NS065840</funding_grant_id><funding_grant_id>R01 HD073115</funding_grant_id><funding_grant_id>U10 NS077311</funding_grant_id><funding_grant_id>U01 NS045911</funding_grant_id><pubmed_authors>McDonough TL</pubmed_authors><pubmed_authors>Wilfong A</pubmed_authors><pubmed_authors>Carpenter JL</pubmed_authors><pubmed_authors>Gaillard WD</pubmed_authors><pubmed_authors>Williams K</pubmed_authors><pubmed_authors>Gainza-Lein M</pubmed_authors><pubmed_authors>Mikati MA</pubmed_authors><pubmed_authors>Goldstein JL</pubmed_authors><pubmed_authors>Abend NS</pubmed_authors><pubmed_authors>Chapman KE</pubmed_authors><pubmed_authors>Riviello J</pubmed_authors><pubmed_authors>Peariso K</pubmed_authors><pubmed_authors>Kapur K</pubmed_authors><pubmed_authors>Goodkin HP</pubmed_authors><pubmed_authors>Wainwright MS</pubmed_authors><pubmed_authors>Jackson MC</pubmed_authors><pubmed_authors>Arya R</pubmed_authors><pubmed_authors>Sanchez Fernandez I</pubmed_authors><pubmed_authors>Brenton JN</pubmed_authors><pubmed_authors>Topjian AA</pubmed_authors><pubmed_authors>Glauser TA</pubmed_authors><pubmed_authors>Helseth A</pubmed_authors><pubmed_authors>Tasker RC</pubmed_authors><pubmed_authors>Loddenkemper T</pubmed_authors><pubmed_authors>pediatric Status Epilepticus Research Group (pSERG)</pubmed_authors></additional><is_claimable>false</is_claimable><name>Refractory status epilepticus in children with and without prior epilepsy or status epilepticus.</name><description>&lt;h4>Objective&lt;/h4>To compare refractory convulsive status epilepticus (rSE) management and outcome in children with and without a prior diagnosis of epilepsy and with and without a history of status epilepticus (SE).&lt;h4>Methods&lt;/h4>This was a prospective observational descriptive study performed from June 2011 to May 2016 on pediatric patients (1 month-21 years of age) with rSE.&lt;h4>Results&lt;/h4>We enrolled 189 participants (53% male) with a median (25th-75th percentile) age of 4.2 (1.3-9.6) years. Eighty-nine (47%) patients had a prior diagnosis of epilepsy. Thirty-four (18%) patients had a history of SE. The time to the first benzodiazepine was similar in participants with and without a diagnosis of epilepsy (15 [5-60] vs 16.5 [5-42.75] minutes, p = 0.858). Patients with a diagnosis of epi</description><dates><release>2017-01-01T00:00:00Z</release><publication>2017 Jan</publication><modification>2025-04-26T12:13:57.812Z</modification><creation>2019-03-26T22:58:03Z</creation></dates><accession>S-EPMC5272971</accession><cross_references><pubmed>28011930</pubmed><doi>10.1212/WNL.0000000000003550</doi><doi>10.1212/wnl.0000000000003550</doi></cross_references></HashMap>